Primecap Management CO Exact Sciences Corp Transaction History

Primecap Management CO

$136 Billion
Q2 2024

A detailed history of Primecap Management CO transactions in Exact Sciences Corp stock. As of the latest transaction made, Primecap Management CO holds 496,300 shares of EXAS stock, worth $32.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

496,300

Previous 479,300 3.55%

Holding current value

$32.7 Million

Previous $33.1 Million 36.65%

% of portfolio

0.02%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$41.33 - $74.26 $702,610 - $1.26 Million	17,000 Added 3.55%	496,300 $21 Million
Q2 2022 Aug 11, 2022	SELL	$35.61 - $76.23 $890,250 - $1.91 Million	-25,000 Reduced 4.96%	479,300 $18.9 Million
Q1 2022 May 11, 2022	SELL	$57.56 - $82.54 $1.61 Million - $2.31 Million	-28,000 Reduced 5.26%	504,300 $35.3 Million
Q4 2021 Feb 11, 2022	SELL	$72.5 - $100.68 $2.79 Million - $3.88 Million	-38,500 Reduced 6.74%	532,300 $41.4 Million
Q3 2021 Nov 12, 2021	SELL	$90.24 - $124.05 $451,200 - $620,250	-5,000 Reduced 0.87%	570,800 $54.5 Million
Q2 2021 Aug 10, 2021	SELL	$93.66 - $139.27 $842,940 - $1.25 Million	-9,000 Reduced 1.54%	575,800 $71.6 Million
Q1 2021 May 14, 2021	SELL	$116.57 - $155.01 $8.23 Million - $10.9 Million	-70,600 Reduced 10.77%	584,800 $77.1 Million
Q4 2020 Feb 08, 2021	SELL	$99.61 - $142.12 $116 Million - $166 Million	-1,165,600 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$72.92 - $102.01 $10.2 Million - $14.3 Million	-140,500 Reduced 10.76%	1,165,600 $119 Million
Q2 2020 Aug 13, 2020	SELL	$55.75 - $92.75 $4.86 Million - $8.08 Million	-87,100 Reduced 6.25%	1,306,100 $114 Million
Q1 2020 May 14, 2020	SELL	$37.9 - $104.44 $4.29 Million - $11.8 Million	-113,300 Reduced 7.52%	1,393,200 $80.8 Million
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $465,960 - $598,440	6,000 Added 0.4%	1,506,500 $139 Million
Q3 2019 Nov 13, 2019	SELL	$90.37 - $122.49 $25.5 Million - $34.6 Million	-282,600 Reduced 15.85%	1,500,500 $136 Million
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $108 Million - $142 Million	-1,206,100 Reduced 40.35%	1,783,100 $210 Million
Q1 2019 May 14, 2019	SELL	$61.98 - $96.5 $12.8 Million - $19.9 Million	-205,902 Reduced 6.44%	2,989,200 $259 Million
Q4 2018 Feb 12, 2019	SELL	$56.04 - $82.66 $21.5 Million - $31.7 Million	-383,998 Reduced 10.73%	3,195,102 $202 Million
Q4 2017 Feb 13, 2018	SELL	$46.49 - $60.51 $25.9 Million - $33.7 Million	-557,600 Reduced 13.48%	3,579,100 $188 Million
Q3 2017 Nov 13, 2017	BUY	$37.05 - $47.12 $153 Million - $195 Million	4,136,700	4,136,700 $195 Million

Others Institutions Holding EXAS

# of Institutions

610

Shares Held

166M

Call Options Held

1.93M

Put Options Held

1.23M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $11.7B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Exact Sciences Corp Transaction History